Henan Genuine Biotech Co., Ltd.

This study tests whether adding a new drug, GEN-725, to the existing drug dositinib is safe and works better for people with advanced lung cancer that has a specific EGFR gene mutation. About 110 adults aged 18-75 will take part. The goal is to shrink tumors and control the disea…

This early-stage study tests a new tablet called GEN-725 in about 48 adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check the drug's safety and find the right dose, while also looking for signs that it can shrink tumor…

This study tests a new experimental drug called CL-197 in 24 adults with HIV-1 who have never taken any HIV medication. The goal is to see how well the drug lowers the amount of virus in the blood and to check for side effects over about two weeks. Participants will receive a sin…

This study tests a new drug called dositinib for people with advanced non-small cell lung cancer that has a specific genetic change (EGFR mutation). The goal is to find a safe dose and see if the drug can shrink tumors. About 153 adults aged 18-75 who have already tried other tre…